No. of Pages: 149 | Report Code: TIPRE00025050 | Category: Life Sciences
放射治疗主要用于控制肿瘤的生长，并尽量减少对周围正常和健康组织的暴露。放射治疗使用高能辐射（通常是 X 射线）来破坏癌细胞并治疗前列腺、乳房、头部和身体部位的肿瘤。颈部、肺部以及身体任何其他需要进行放射治疗的部位。过去几年，随着成像方式、强大的计算机、软件和传输系统的改进使技术成为可能，放射治疗取得了进展。
因此，预计该地区癌症患病率的上升将导致未来几年对放射治疗的巨大需求，预计将进一步推动放射治疗市场的发展。
随着癌症患病率的不断上升，此次大流行中的放射治疗市场正在不断增长，放射治疗是一种高效且成本低廉的治疗方法。 -有效的治疗。非洲有 54 个国家，是仅次于亚洲的第二人口大国。鉴于非洲医疗保健系统的缺陷，预计 COVID-19 大流行的影响将是灾难性的。非洲肿瘤学界发布了几项针对放射肿瘤科的实践指南，包括推迟放疗、继续治疗、大分割甚至省略放疗的优先标准。
中东和非洲的放射治疗市场预计从 2021 年的 3.170 亿美元增长到 2028 年的 4.109 亿美元；预计 2021 年至 2028 年复合年增长率为 3.8%。2019 年 12 月，Elekta 与 ViewRay, Inc. 签署战略合作，以增强 MR 引导放射治疗的功能和应用。作为合作的一部分，Elekta 投资了 ViewRay Inc.，相当于 ViewRay 9.9% 的股份。两家公司还同意致力于减少辐射暴露，以获得更好的治疗效果。专注于此类技术的开发最终将在未来几年推动放射治疗的采用，从而最终促进市场增长。
从类型来看，2020年中东和非洲放疗市场中，外照射放射治疗细分市场占据最大份额。从产品来看，外照射放疗产品细分市场在2020年中东和非洲放疗市场中占据最大份额。 从应用来看，乳腺癌细分市场在2020年中东和非洲放疗市场中占据最大份额。从用户来看，2020年医院细分市场在放射治疗市场中占有较大的市场份额。
准备本中东和非洲放射治疗市场报告时提到的一些主要一手和二手来源是公司网站、年度报告、报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司包括：Siemens Healthineers AG、Accuray Incorporated、Sumitomo Heavy Industries, Ltd.、Hitachi, Ltd.、Koninklijke Philips NV、Brainlab AG 和 Varian Medical Systems, Inc.
按类型
按产品
按申请
作者最终用户
按国家/地区
Strategic insights for Middle East and Africa Radiotherapy involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 317.0 Million |
| Market Size by 2028 | US$ 410.9 Million |
| Global CAGR (2021 - 2028) | 3.8% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 中东和非洲
|
| Market leaders and key company profiles |
The regional scope of Middle East and Africa Radiotherapy refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Middle East and Africa Radiotherapy Market is valued at US$ 317.0 Million in 2021, it is projected to reach US$ 410.9 Million by 2028.
As per our report Middle East and Africa Radiotherapy Market, the market size is valued at US$ 317.0 Million in 2021, projecting it to reach US$ 410.9 Million by 2028. This translates to a CAGR of approximately 3.8% during the forecast period.
The Middle East and Africa Radiotherapy Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Radiotherapy Market report:
The Middle East and Africa Radiotherapy Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Radiotherapy Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Radiotherapy Market value chain can benefit from the information contained in a comprehensive market report.
E 1803, Panchshil Towers, Vagholi, Haveli, Pune- 412207, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Radiotherapy Market
